Abstract: A patient support apparatus includes a frame, a patient support surface, one or more force sensors that detect weight on the patient support surface, a recharger, and a controller. The recharger is adapted to recharge a personal electronic device of the patient's. The controller controls power supplied to the recharger based on outputs from the force sensors. Additionally or alternatively, a barrier is provided having a coil therein. The recharger includes a magnet for magnetically coupling to the barrier, and the recharger wirelessly receives power from the coil when the recharger is magnetically coupled to the barrier. Alternatively, the magnet holds a personal electronic device that receives power wirelessly from a coil inside the barrier. In still another variation, a pendant is included for controlling movement of the patient support apparatus and the pendant includes a recharger adapted to recharge a personal electronic device.

Abstract: A method of assisting a caregiver in delivering patient therapy includes providing prompts at a user interface, wherein the therapy includes steps in a protocol, at least one of which is an instruction for the caregiver to call the ERC by actuating the input device, initiating a call to an emergency response center (ERC) in response to actuation of an input device of a medical device, detecting, by one or more sensors, whether one or more steps of the protocol have been completed in response to the prompts, wherein at least one of the sensors is a sensor other than a therapy electrode, selecting one or more prompts based at least in part on whether the one or more steps in the series has been performed, and controlling the user interface to provide the selected one or more prompts as visible and/or audible prompts.

Abstract: Transfer apparatus designed as a mobile, generally C-shaped frame assembly including top and bottom portions removably connected by at least one spacer and a seat adapted to support a patient in a sitting or suspended sitting position at multiple levels. A horizontal part of the top portion is a seat support, the bottom portion is a wheeled base, and spacers fix a selected height of the seat support. The apparatus operates on patient support surfaces with and without vertical movement capability, enables use of a commode over and away from the bed by the patient in a seating position, and enables changing of a seat under the sitting patient. The transfer apparatus provides a cost effective, lightweight, rigid, without moving parts mobile seat support assembly as a commode/wheelchair (C/W) capable of performing multifunctional safe patient transfer to and from patient support surfaces with and without vertical movement.

Abstract: A table system for use with an imaging device includes a base portion that supports the table system over a support surface, a patient support including a platform for supporting a patient in a standing position and a bed for supporting the patient in a lying position, a linkage portion coupled between the base portion and the patient support that is pivotable with respect to both the base portion and the patient support, a first drive mechanism that drives the pivoting of the patient support with respect to the linkage portion, and a second drive mechanism that drives the pivoting of the linkage portion with respect to the base portion, the first and second drive mechanisms moving the patient support between a vertical position in which the platform is substantially parallel to the support surface and a horizontal position in which the bed is substantially parallel to the support surface.

Abstract: During orthopedic surgeries, body parts are moved in different ways to cause different anatomic features (e.g. muscles or the trochanters) to tighten or loosen, or become more or less prominent during the intended surgical incisions, which can result in easier surgical procedures. Body parts can be moved using a variety of different structures. The exemplary structures described herein can allow for: (1) a person's leg and foot to be rotated about the axis of the leg (i.e., femur/tibia axis); (2) a person's leg can be pivoted generally about the hip/femoral head/acetabulum to vary the angle between the axis of the leg and a median sagittal plane; (3) a person's leg can be moved in a direction parallel to the leg axis; and/or a person's leg can be pivoted in a generally vertical plane, about the femoral head/acetabulum while the axis of the leg and the median sagittal plane remaining substantially parallel.

Abstract: A patient securing overlay is provided that includes a sheet of fabric for supporting a patient's torso on a surgical table. The sheet of fabric has an upper surface configured to face the patient and a lower surface configured to face a surgical table mattress or underbody support. The sheet of fabric includes friction enhancing elements applied to at least a portion of the upper surface thereof. The sheet of fabric can include an extension at a foot end of the sheet of fabric that provides material to be tucked under a foot end of the surgical table mattress or underbody support for securing the foot end of the sheet of fabric to the surgical table mattress or underbody support. The extension can include one or more friction enhancing elements.

Abstract: A wearable thorax percussion device for dislodging mucous buildup in the airways of a human patient, the device comprising frame elements and electromechanical actuators retained by the frame elements to intermittently percuss the thorax, and an electronic controller and power source for generating and modulating an electrical signal to energize the actuator. The frame elements may be interconnected by a garment, or fasteners and elastic or adjustable strapping.

Abstract: Various implementations include a device for assisting with and controlling stretching of a limb of a patient. The device includes a limb support for receiving the limb, a base, and a coupling that rotatably couples the limb support and the base. The coupling allows the limb support to rotate through various axes of rotation individually, depending on the range of motion expected for the limb. For example, for a device designed for the foot, the coupling allows a foot support to rotate about a first axis, a second axis, and a third axis, wherein the three axes are orthogonal to each other. In other implementations, the device may be designed for other portions of limbs, such as the hand, the forearm, the upper arm, the lower leg, and the upper leg.

Abstract: Provided is a technique for attaching an artificial tendon to a support device having a supporting material as well as a product formed by the technique. The artificial tendon is provided for flexing or extending a joint of a body, when applied at the joint of the body, by way of pulling the artificial tendon along its lengthwise direction. The artificial tendon is attached to the support device by stitching across the tendon with a thread on the supporting material of the support device, which forms a tunnel for the artificial tendon between the supporting material and the stitching. The artificial tendon is able to travel in the tunnel. The tunnel formed by this technique is positioned on the surface of the supporting material of the support device.

Abstract: The current disclosure is directed to embodiments of an apparatus, method and systems for collapsing/lowering an exoskeleton device including at least one motor and at least one component. In some embodiments, the device is configured to be moved by the at least one motor. When at least one of any of a plurality of faults including power faults such as a low power fault and a power failure fault, electrical faults, software faults and mechanical faults, is detected in the powering the exoskeleton device, one or more components of the device may be decelerated via the at least one motor.

Abstract: A walking assistance apparatus includes a suit to be worn on a knee and waist of a user, a first wire that couples a portion included in the suit and worn above the knee to a portion included in the suit and worn on the waist, a second wire that couples a portion included in the suit and worn above a back of the knee to a portion included in the suit and worn on the waist, and motors coupled to the first and second wires. The motors are controlled to generate tensions so that each of the first and second wires has a stiffness greater than 200 N/m during a first period including a period of 95% or more and 100% or less of a first gait cycle of the user and a period of 0% or more and 50% or less of a second gait cycle subsequent to the first gait cycle.

Abstract: A driving module and a motion assistance apparatus including the same may be provided. For example, the driving module including a driving source disposed on one side of a user, and configured to provide power, a first decelerator including a first input terminal coupled to the driving source, and a first output terminal and a second output terminal configured to receive power from the first input terminal, a second decelerator including a second input terminal coupled to the first output terminal, and a third output terminal and a fourth output terminal configured to receive power from the second input terminal, and a third decelerator including a third input terminal coupled to the second output terminal, and a fifth output terminal and a sixth output terminal configured to receive power from the third input terminal may be provided.

Abstract: The present invention relates to a method of diagnosing the primary lesions that give rise to a chronic condition or incorrect structure in myofascial units and associated structures in a human patient. The invention also relates to a method of therapeutic treatment of the diagnosed conditions, in particular by application of a variable vacuum stimulus.

Abstract: A portable compression system for preventing deep vein thrombosis is provided. The portable compression system includes an inflatable apparatus comprising a monitor unit and at least one inflatable air cell. The portable compression system further includes an outer cuff comprising a pocket configured to receive the inflatable apparatus, the outer cuff configured to be wrapped around a portion of a patient's body where prevention of deep vein thrombosis is desired. The portable compression system further includes a disposable sleeve barrier configured to provide a physical barrier between the outer cuff and the portion of the patient's body.

Abstract: Disclosed embodiments provide an improved stimulation device. Embodiments of the improved stimulation device include a cup and a driver. The cup has a cavity surrounded by a rim. In use, a user positions the rim such that an opening to the cavity is over an area to be stimulated (for example, the clitoris). A sealed-, or substantially-sealed, chamber is formed by the cavity walls and the user's skin (surrounding the clitoris). A pressure field is generated in the chamber without generating a pressure below a reference pressure, which is gauge pressure reading of zero. In some embodiments, this is achieved by a driver configured to vary a volume of the cavity in such a way that the varied volume is not larger than an initial volume. In some embodiments, the stimulation device is a sex toy. In some embodiments, the stimulation device is a medical device.

Abstract: A massage attachment assembly that includes a base portion having a proximal end and a distal end, and a contact portion having a proximal end and a distal end. The base portion includes an attachment member on the proximal end that is configured to secure the base portion to a percussive massage device. The proximal end of the contact portion is removably secured to the distal end of the base portion.

Abstract: A vibratory treatment device has a motor driving an output shaft on which is mounted an eccentric weight to create vibration of the motor as the shaft rotates. A frame is connected to the motor to which frame said vibrations are transmitted through the connection of the frame to the motor. A pad surrounds the frame and into which said vibrations of the frame are transmitted. The pad is applied to the affected limb or limbs of the patient and activated to cause vibrations of the motor to be transmitted through the frame and pad into the tissue of the patent's limb or limbs. The treatment is continued for a therapeutically effective period of time and repeated periodically.

Abstract: A system for assisting a rescuer with treatment of a patient comprising a mobile computing device that includes a user interface and a processor coupled to memory. The processor configured to cause the user interface to prompt the rescuer to select a proficiency level from a plurality of proficiency levels, the plurality of proficiency levels comprising a basic proficiency level and at least one non-basic proficiency level, wherein the basic proficiency level includes basic resuscitation instructions for the rescuer. The system further configured to receive an input from the rescuer of the selected proficiency level. The system provides, if the rescuer selects the basic proficiency level, the basic resuscitation instructions to the rescuer and provide, if the rescuer selects the at least one non-basic proficiency level, non-basic instructions to the rescuer. Lastly, the system transmits signals to control a defibrillator according to the selected proficiency level.

Abstract: Provided is a bidet device. The bidet device according to the present invention comprises: a seat as a place to sit; a steaming chamber housing which is imbedded in a bidet tank coupled to one side of the seat and has built-in parts therein; a nozzle for hip fumigation, which is connected to the steaming chamber housing for jetting medicinal steam; and a steam generator which is provided in the steaming chamber housing and connected to the nozzle for hip fumigation, allowing the medicinal steam and medicinal extracts generated for hip-fumigation bath to be supplied to the nozzle for hip fumigation, wherein the steam generator and a medicine container of the steaming chamber disposed in the steaming chamber housing are integrally installed to eject the fumigated medicinal steam and medicinal extracts of drugs into a stool.

Abstract: Systems, methods, and kits useful for cleansing the eyelids and maintaining eyelid hygiene are disclosed. In one embodiment, a system for treating or cleansing an ocular region is disclosed. The system consists essentially of: (A) a tubular applicator, wherein the applicator comprises: (i) a first chamber and a second chamber; and (ii) a sealable element situated between the first chamber and the second chamber, wherein at least the second chamber is substantially pre-filled with an ocular composition, and (B) a dispenser, wherein the dispenser is bonded to an external surface of a first end of the applicator.

Abstract: Device (100) for reconstituting an active ingredient in sterile powder, comprising a vial (4) containing the active ingredient; a flexible bag (1) containing a sterile liquid; a connecting component (5) secured to the vial (4) and to the flexible bag (1); an elastomeric sealing ring (10) arranged between the connecting component (5) and the vial (4), an axially perforated spike (7), constrained to the connecting component (5), wherein a sterile chamber (70) is provided, delimited by the vial (4), by the connecting component (5) and by the sealing ring (10, 110), whereby the active ingredient is reconstituted in sterile conditions.

Abstract: A method is for preparing a medical/chemical solution by mixing a medical/chemical substance housed in a sealed container with a solution housed in a bag. The method includes transferring, from the bag into a syringe, an amount of the solution that is to be injected into a plurality of the containers. With the container and the syringe being held, at least one of a robot and a syringe driver configured to drive a plunger of the syringe is controlled so as to inject the amount of the solution into the plurality of the containers from the syringe.

Abstract: An oral varnish comprising a combination of two different viscosity dimethicone components, wherein the difference between the two different viscosity dimethicone components is about 2.0 million cP or greater; and comprising at least one active ingredient, which is preferably a fluoride donor.

Abstract: Radically polymerizable dental material, which contains at least one encapsulated photochromic colorant.

Abstract: Disclosed is a resin modified dental luting cement composition having a polymerizable resin component, a polyacidic polymer component, a filler component, a redox initiator system, and water.

Abstract: The present invention relates to an aqueous composition comprising (i) at least hydrogel beads comprising 2 gelling agents chosen from (hetero)polysaccharides, (ii) at least one foaming surfactant, and (iii) at least anacrylic copolymer of acrylic acid and C10-C30 alkyl acrylate. The present invention further relates to the use of said composition as a cleansing scrub composition of the skin.

Abstract: There is provided a gel composition that can be suitably used as a thickener for cosmetic preparations and the like. A gel composition comprising a neutralized product of an alkyl-modified carboxyl group-containing polymer, which is a copolymer of monomers comprising 100 parts by mass of (meth)acrylic acid (a), 2.5 to 5 parts by mass of a (meth)acrylic acid alkyl ester (b) in which the alkyl group has 18 to 24 carbon atoms, and 0.1 part by mass or less of a compound (c) having two or more ethylenically unsaturated groups; and at least one of an anionic emulsifier and a nonionic emulsifier.

Abstract: A process for making a foamed composition, comprising the steps of a. providing a liquid hair treatment composition, b. providing a foaming device comprising a chamber, a removable or rechargeable pressurised gas unit and a dispensing nozzle, c. placing the liquid hair treatment composition in the chamber of the foamin device, d. charging the chamber with the gas, e. mixing the liquid hair treatment composition with the gas, and f. operating said foaming device such that the composition is ejected from the nozzle as a foam, wherein the liquid hair treatment composition comprises at least one conditioning ingredient and is free from hair styling polymer.

Abstract: Reduced-ethanol perfume compositions according to the invention comprise specific combinations of acrylates/VA copolymer and acrylates copolymer in an aqueous base or delivery vehicle. The perfume compositions according to the invention are easy to manufacture and provide an aqueous perfume composition that preserves aromatic integrity (intensity, duration and range), even in emulsion form. The most advantageous use of compositions of the invention are as parfums, eau de parfums, eau de toilettes, and colognes. However, the invention may also find use in many types of fragranced products, such as those used on the skin and hair of humans or animals, in cleaning products of all types, in air deodorizers, air fresheners, and more.

Abstract: A water-in-oil personal care emulsion with water droplets size below 20 microns, the droplets containing solubilized cystine. A process of making an emulsion is also described.

Abstract: This invention relates to a dentifrice comprising (i) at least one source of ionic tin; and (ii) an antibacterial system comprising caprylyl glycol together with 3-phenyl-1-propanol, phenethyl salicylate, or both 3-phenyl-1-propanol and phenethyl salicylate, as well as to methods of using and of making these compositions.

Abstract: An oral care composition comprising high water oral care compositions comprising an orally acceptable carrier, zinc phosphate, a first stannous ion source (i.e., stannous fluoride), and a second stannous ion source (i.e., stannous chloride). Methods and uses for this composition are also described throughout.

Abstract: The present disclosure relates to cosmetic agents, which in addition to a deodorant agent contain a combination of special aromatic alcohols and certain menthyl compounds. These agents have a long-lasting deodorizing effect. The present disclosure also relates to a cosmetic product that includes the cosmetic agent as contemplated herein, as well as at least one propellant. The present disclosure also relates to the use of the agent as contemplated herein to treat body odor, as well as the use of a combination of aromatic alcohol and menthyl compounds to improve the odor-inhibiting effect of cosmetic agents over a period of from about 24 to about 48 hours.

Abstract: The present disclosure concerns a perfuming ingredient of a compound of formula (I) in the form of any one of its stereoisomers or a mixture thereof, and wherein X represents a CHO group when R1 represents a C1-2 alkyl group or X represents a CH(R6)CHO group when R1 represents a hydrogen atom or a C1-2 alkyl group. Each of R2, R3, R4, R5 and R6 represents, independently from each other, a hydrogen atom or a C1-2 alkyl group; or R3 and R4 represent, when taken together, a ethanediyl group; and —C(R3)(R4)—CH(R5)—OH group is, relative to position 1, an ortho, a meta, a para substituent of the aromatic ring or a mixture thereof. Also disclosed is the compound of formula (I) as part of a perfuming composition or of a perfumed consumer product.

Abstract: A non-aqueous hair leave-on composition directed to an aqueous hair leave-on composition for hair frizz reduction comprising from about 0.15% to about 12.0% of a moisture control material or mixture of moisture control materials wherein the moisture control material is selected from one or more of the Class II groups a, b, c, d, e, f and g and wherein the moisture control material of Class II is weakly to non-acidic and further wherein the moisture control material of Class II has protein binding higher than 10 and molecular volume lower than 1500 and log P higher than 0.5 and pKa of 5 or higher and hydrogen-binding higher than 4; and wherein, the non-aqueous carrier is selected from a group consisting of a) hydrocarbons b) silicone fluid c) non-hydrocarbons volatile organic solvents or mixtures thereof.

Abstract: The present invention relates to an aqueous cosmetic composition based on a bicarbonate salt, said composition being stabilized by a pair of particular gelling agents, and also to the cosmetic use thereof as a deodorant. It also relates to a roll-on deodorant containing this composition.

Abstract: A compound that has retinol like properties is used in compositions for treating the skin.

Abstract: Hair cleaning agents and methods for improving the care properties of hair are provided. An exemplary hair cleaning agent contains anionic surfactant and a specific oil mixture. The oil mixture may include (i) at least one mono- and/or diester of glycerol and a saturated or unsaturated, branched or unbranched carboxylic acid having 18 to 30 carbon atoms, (ii) at least one vegetable oil, (iii) at least one cationic guar polymer, and (iv) at least one amidoamine of a selected formula.

Abstract: Mixtures comprising a selected cooling active ingredient (E)-3-benzo[1,3]dioxol-5-yl-N,N-diphenyl-2-propenamide and at least one other substance which acts as a solvent for (E)-3-benzo[1,3]dioxol-5-yl-N,N-diphenyl-2-propenamide, wherein the substance is selected form the group consisting of benzyl benzoate, diethyl succinate, triethyl citrate, triacetin, ethanol, peppermint oil, anethol, optamint, propylene glycol, further cooling active ingredients or mixtures thereof.

Abstract: Oral care compositions comprising citrulline and stannous ion source with a specific pH range are provided for promoting Gum Health of a user.

Abstract: The present invention relates to a process for dyeing keratin fibres, in particular human keratin fibres such as the hair, using one or more particular azinium dyes and one or more fluorescent dyes. The present invention also relates to a cosmetic composition comprising the dyes defined above, and also to a multi-compartment device containing said dyes. The present invention also relates to the use of said dyes for dyeing light keratin fibres, especially human keratin fibres such as the hair, in chestnut-brown, dark chestnut-brown, brown, brown with a glint, or even black, without using an additional dye other than those defined above.

Abstract: Cosmetic or pharmaceutical compositions are described herein for application to skin, hair and/or a nail of a subject, as well as methods utilizing same for administering hydrogen peroxide to skin, hair and/or a nail, and kits for applying same. The compositions comprise a hydrogen peroxide-producing enzyme, and a substrate of the hydrogen peroxide-producing enzyme. Further described herein are cosmetic compositions and kits for lightening skin and/or hair, which further comprise a lignin peroxidase, as well as cosmetic methods utilizing same.

Abstract: Disclosed is a topical skin composition. The composition can include water, caprylic/capric triglyceride, Butyrospermum parkii (shea) butter, Helianthus annuus (sunflower) seed oil, cetyl alcohol, glyceryl stearate, and beeswax.

Abstract: The present disclosure relates to a hair care compositions comprising at least two or more polysaccharides, one or more monomeric polyols, and water. The compositions may also include polyglycerol esters of fatty acids. The hair care compositions are particularly useful in methods for imparting durable styling or shaping benefits and/or frizz control to hair.

Abstract: The invention relates to a composition, especially a cosmetic composition, comprising at least one acrylic thickener and at least one oil, as well as to methods of using such compositions.

Abstract: The present disclosure relates to an antiperspirant cosmetic agent containing: a) from about 0.5 to about 7.0% by weight of at least one copolymer formed from the monomers i) N-tert-octylacrylamide ii) acrylic acid iii) tert.-butylaminoethyl methacrylate iv) and optionally further monomers b) from about 40 to about 75% by weight of oil that is liquid at about 20° C. and about 1.013 hPa wherein the antiperspirant cosmetic agent does not contain any aluminium-containing compounds, use thereof, and methods using an agent of this kind.

Abstract: The present invention relates to a skin external composition containing an extract of green tea produced by an extreme light-shielding cultivation method, which is distinguished from a conventional light-shielding cultivation method of green tea. More specifically, the present invention relates to a skin external composition, which contains an extract of green tea cultivated by extreme light-shielding, in which the amino acid content is remarkably increased by cultivating the green tea by a light-shielding cultivation under a light-shielding rate of 99% or more, thereby obtaining more excellent skin moisturizing, skin protecting, and anti-aging effects.

Abstract: A coconut shell extract characterized by a particular level of trans-piceatanol and cosmetic and/or dermatological compositions comprising the coconut shell extract. Methods comprising a cosmetic application of at least one of compositions.

Abstract: The invention can selectively heat a diseased area in the lung while minimizing heating to the healthy area and surrounding tissue. This is done by exposing the lung to an electromagnetic field causing dielectric or eddy current heating. The invention is particularly useful for treating emphysema as the diseased areas have reduced blood flow. The diseased area will heat up rapidly while the healthy tissue will be cooled by the blood flow. This is particularly effective for treating emphysema because of the low mass of the lungs and the high blood flow. To avoid heating of surrounding organs the direction of the electromagnetic energy is switched in a way it always passes through lungs but only intermittently passes through adjacent organs. If heat activated drugs are present in the lungs, they are selectively released in the heated tissue.

Abstract: The present disclosure provides programmable osmotic-controlled oral compositions providing delayed release of a therapeutically acceptable amount of a drug. The programmable osmotic-controlled compositions of the disclosure provide a lag time that is independent of the presence or absence of food, type of food, pH, gastric emptying, gastric motility, and volume and viscosity of gastric fluid. The compositions of the disclosure can be programmed to provide a desired and precise lag time, and release drug, after the lag time, at a rhythm, e.g., that matches the human circadian rhythm of a condition's symptoms and/or of the individual being treated in the application of the therapy to optimize therapeutic outcome and minimize side effects.